The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Novel inflammatory biomarkers in acute coronary syndrome

  • Sim, Doo Sun (Division of Cardiovascular Medicine, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School) ;
  • Ahn, Youngkeun (Division of Cardiovascular Medicine, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School)
  • Published : 2013.03.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Braunwald E. Unstable angina: an etiologic approach to management. Circulation 1998;98:2219-2222. https://doi.org/10.1161/01.CIR.98.21.2219
  2. Suleiman M, Aronson D, Reisner SA, et al. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med 2003;115:695-701. https://doi.org/10.1016/j.amjmed.2003.06.008
  3. Mega JL, Morrow DA, De Lemos JA, et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 2004;44:335-339. https://doi.org/10.1016/j.jacc.2004.04.033
  4. Harb TS, Zareba W, Moss AJ, et al. Association of Creactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction. Am J Cardiol 2002;89:216-221. https://doi.org/10.1016/S0002-9149(01)02204-4
  5. Naruko T, Ueda M, Haze K, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002;106:2894-2900. https://doi.org/10.1161/01.CIR.0000042674.89762.20
  6. Baldus S, Heeschen C, Meinertz T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003;108:1440-1445. https://doi.org/10.1161/01.CIR.0000090690.67322.51
  7. Mocatta TJ, Pilbrow AP, Cameron VA, et al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 2007;49:1993-2000. https://doi.org/10.1016/j.jacc.2007.02.040
  8. Lund J, Qin QP, Ilva T, et al. Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003;108:1924-1926. https://doi.org/10.1161/01.CIR.0000096054.18485.07
  9. Kelly D, Khan SQ, Thompson M, et al. Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction. Eur Heart J 2008;29:2116-2124. https://doi.org/10.1093/eurheartj/ehn315
  10. Kelly D, Khan S, Cockerill G, et al. Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction. Eur J Heart Fail 2008;10:133-139. https://doi.org/10.1016/j.ejheart.2007.12.009
  11. Guzel S, Serin O, Guzel EC, Buyuk B, Yilmaz G, Guvenen G. Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction. Korean J Intern Med 2013;28:165-173. https://doi.org/10.3904/kjim.2013.28.2.165